Intended for healthcare professionals


Bone marrow transplants show no benefit for non-Hodgkin's lymphoma

BMJ 2001; 322 doi: (Published 20 January 2001) Cite this as: BMJ 2001;322:127
  1. Scott Gottlieb
  1. New York

    Patients with aggressive non-Hodgkin's lymphoma do just as well when they are given standard chemotherapy for first line treatment as they do when they are treated with high dose chemotherapy and receive a bone marrow transplant, a new study shows.

    The findings suggest that the more powerful and risky treatment of high dose chemotherapy followed by autologous bone marrow transplant should be reserved for patients in whom other treatments have failed, according to lead author Dr Hanneke Kluin-Nelemans …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription